Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-30 · accession 0001415889-24-015147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-03 | 2024-05-30 | CLDX | Martin Samuel Bates | SVP AND CFO | S - Sale+OE | $34.05 | -35.0K | 25.1K | -58% | -$1.19M |
| D | 2024-06-03 | 2024-05-30 | CLDX | Martin Samuel Bates | SVP AND CFO | M - OptEx | $10.38 | +25.0K | 60.1K | +71% | +$259.5K |
| D | 2024-06-03 | 2024-05-30 | CLDX | Martin Samuel Bates | SVP AND CFO | M - OptEx | $0.00 | -25.0K | 80.6K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | S | D | 35,000 | $34.05 | 25,128 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.69 to $34.55 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 2 | Common | Common Stock | 2024-05-30 | M | A | 25,000 | $10.38 | 60,128 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2024-05-30 | M | D | 25,000 | $0.00 | 80,600 | D | $10.38 · — to 2030-06-18 | 25,000 Common Stock | (F2) 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. |